10x Genomics

$10x Genomics(TXG)$ 自选股里躺了2年多，今天进一点仓位。
在单细胞相关方面，10x目前是绝对的领导者

$10x Genomics(TXG)$
1. 摘要与核心观点
10x Genomics是全球领先的生命科学技术平台公司，通过推动生物学从“批量”测量转向高分辨率、多维度的单细胞与空间组学分析，致力于构建下一代科学发现的基础设施。本文分析认为：
1. 市场定位：公司正处于从高速增长的“技术颠覆者”向稳健...

$10x Genomics(TXG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000400  Size: 4 KB 网页链接

$10x Genomics(TXG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000399  Size: 4 KB 网页链接

$10x Genomics(TXG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001140361-25-041820  Act: 34  Size: 11 KB 网页链接

$10x Genomics(TXG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-26-000003  Size: 11 KB 网页链接

$10x Genomics(TXG)$ 8-K Current report, item 2.02 Accession Number: 0001628280-26-001808  Act: 34  Size: 899 KB 网页链接

$10x Genomics(TXG)$ 144 Report of proposed sale of securities Accession Number: 0001786720-25-000004  Act: 33  Size: 4 KB 网页链接

$10x Genomics(TXG)$ 8-K Current report, item 5.02 Accession Number: 0001628280-25-052154  Act: 34  Size: 667 KB 网页链接

$10x Genomics(TXG)$ 144 Report of proposed sale of securities Accession Number: 0001786391-25-000004  Act: 33  Size: 4 KB 网页链接

$10x Genomics(TXG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-25-000398  Size: 7 KB 网页链接

$10x Genomics(TXG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000315066-26-000056  Act: 34  Size: 14 KB 网页链接

$10x Genomics(TXG)$ 144 Report of proposed sale of securities Accession Number: 0001971187-25-000004  Act: 33  Size: 4 KB 网页链接